Here you can find the archive of all Press Releases prior to 2021
Filter by date:
Showing 973 press releases before 2021
-
Imfinzi demonstrated unprecedented survival in unresectable, Stage III non-small cell lung cancer with an estimated 50% of patients surviving four years
-
AstraZeneca acquires oral PCSK9 inhibitor programme from Dogma Therapeutics
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
AstraZeneca to list US ADR equity and all US debt securities on Nasdaq
-
Fasenra met both co-primary endpoints of reduced nasal polyp size and blockage in the OSTRO Phase III trial for patients with chronic rhinosinusitis with nasal polyps
-
Statement on AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary pause
-
Biopharma leaders unite to stand with science
-
AstraZeneca aims to transform cancer treatment and advance clinical practice with data presented at ESMO 2020
-
New analyses from Breztri Aerosphere Phase III ETHOS trial to be presented at the European Respiratory Society International Congress 2020
-
Imfinzi approved in the EU for the treatment of extensive-stage small cell lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore